Xylyx Bio
February 11, 2025
Plymouth
Regenerative Medicine
.png)
Xylyx Bio is a regenerative medicine company developing a platform of bioengineered human organs aimed at increasing the supply of organs for life-saving transplantation. The company's lead product is a first-in-class biologic for lung transplant that completed pre-clinical validation and is preparing for clinical stage first-in-human transplant in late 2025. Pipeline includes products for liver, heart, and kidney transplant.
Speakers
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}